Biomarker Discovery Tools Development

Overview: The purpose of the collaboration between Agilent Technologies and Battelle is to extend the depth of biomarker discovery over traditional MudPIT LC/MS/MS approaches. The development is aimed at extending previously developed AMT tag technology to the analysis of more complex mammalian and in particular human proteomes through the inclusion of pI fractionation and the resulting specificity which can be added to the informatics processing.